Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Lantern Pharma Inc (LTRN)

43 + Investors. Track Smart Money conviction in LTRN. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +6
Streak
2Q ▲
Buyers last Q
49%

Smart Money Signals — LTRN

Based on 44 hedge funds · latest filing: 2026 Q3 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added LTRN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
44 hedge funds hold LTRN right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +42% more funds vs a year ago

fund count last 6Q
+13 new funds entered over the past year (+42% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟠

More sellers than buyers — 49% buying

17 buying18 selling
Last quarter: 18 funds reduced or exited vs 17 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~11 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 6 → 4 → 13 → 11. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

41% of holders stayed for 2+ years

■ 41% conviction (2yr+) ■ 23% medium ■ 36% new
18 out of 44 hedge funds have held LTRN for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +42%, value -66%

Value
-65%
Shares
+41%
Last quarter: funds added +42% more shares while total portfolio value only changed -66%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

4 → 6 → 4 → 13 → 11 new funds/Q
New funds entering each quarter: 6 → 4 → 13 → 11. A growing number of institutions are discovering LTRN each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 49% veterans vs 36% newcomers

■ 49% veterans ■ 15% 1-2yr ■ 36% new
Entry-cohort mix of 47 holders: 23 (49%) are 2+ year veterans, 7 entered 1–2 years ago, and 17 (36%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 13% AUM from top-100

13% from top-100 AUM funds
13 of 43 holders rank in the top 100 by AUM, but together hold only 13% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
4.5
out of 10
Moderate Exit Risk
Exit risk score 4.5/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — LTRN

In 2026 Q3, 17 hedge funds were net buyers of LTRN (11 opened a new position, 6 added to an existing one), while 18 reduced or exited (13 trimmed, 5 sold completely) — a 49% buyer ratio, indicating roughly balanced activity. Net buying has persisted for two consecutive quarters, a positive momentum signal. Net fund flow last quarter: +6 funds (more new holders than closures). Total institutional holders: 44.

Hedge Fund Ownership: LTRN

How many hedge funds hold LTRN — quarterly history vs. share price
Quarterly hedge fund ownership of LTRN vs. share price

Market Analysis: LTRN

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: LTRN

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Lantern Pharma Inc (LTRN) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much LTRN has moved relative to its sector benchmark (XLV) since the 2026 Q3 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End September 30, 2026 · 52d ago
LTRN
-71.9%
XLV
+5.4%

LTRN outperformed XLV by -77.3% since September 30, 2026.

Since 13F Filing Date November 14, 2026 · 7d ago
LTRN
-34.4%
XLV
-6.0%

Since the filing became public, LTRN outperformed XLV by -28.4% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

7 top-rated funds 0 high-conviction
Consensus
3.9
/ 10
breadth
×
Elite
0.6
/ 10
conviction
Hedge Fund Positioning: LTRN
43 + Investors

Track Smart Money conviction in LTRN. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q3) Prior (2026 Q2) Change
Funds Holding 43 38 13.16%
13F Shares 4M 3M 41.52%
Total Value $4M $12M -65.69%
New Positions 11 13 -2
Increased Positions 7 9 -2
Closed Positions 5 5 -
Reduced Positions 12 7 +5
Total Calls 2 0 100%
Total Puts 2 0 100%
PUT/CALL Ratio 1.0 0.0 Neutral

Statistics: LTRN

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q3)

43 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in LTRN. Verified SEC 13F-HR filings.

QUARTER:
Top 25 LTRN holders by conviction (% of portfolio weight) — 2026 Q3 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 BIOS Capital Management, LP 0.70% 235,895 $238K
2 Empery Asset Management, LP 0.57% 543,337 $549K
3 CM Management, LLC 0.34% 500,000 $505K
4 Armistice Capital, LLC 0.01% 1,036,000 $1.0M
5 Westside Investment Management, Inc. 0.01% 47,850 $48K
6 Renaissance Technologies LLC 0.00% 368,407 $372K
7 Horizon Kinetics Asset Management LLC 0.00% 22,746 $23K
8 XTX Topco Ltd 0.00% 15,244 $15K
9 Entrust Financial LLC 0.00% 400 —
10 DAVENPORT & Co LLC 0.00% 23,814 $24K
11 Two Sigma Investments, LP 0.00% 141,713 $143K
12 NewEdge Advisors, LLC 0.00% 26,699 $27K
13 PlanVest Financial, Inc 0.00% 100 —
14 Farther Finance Advisors, LLC 0.00% 8,500 $9K
15 Hrt Financial LP 0.00% 30,307 $30K
16 SBI Securities Co., Ltd. 0.00% 2,159 $2K
17 Tower Research Capital LLC (TRC) 0.00% 2,982 $3K
18 Colonial Trust Advisors 0.00% 400 —
19 Squarepoint Ops LLC 0.00% 15,296 $15K
20 UBS Group AG 0.00% 125,416 $127K
21 Focus Partners Wealth 0.00% 15,432 $16K
22 Vanguard Fiduciary Trust Co 0.00% 49,950 $50K
23 Cetera Investment Advisers 0.00% 12,228 $12K
24 IFP Advisors, Inc 0.00% 552 —
25 Vanguard Capital Management LLC 0.00% 420,286 $424K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Lantern Pharma Inc (LTRN)

What does the Smart Money Trend signal show for LTRN?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added LTRN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for LTRN?

More sellers than buyers — 49% buying: Last quarter: 18 funds reduced or exited vs 17 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for LTRN holders?

Smaller funds dominant — 13% AUM from top-100: 13 of 43 holders rank in the top 100 by AUM, but together hold only 13% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held LTRN?

41% of holders stayed for 2+ years: 18 out of 44 hedge funds have held LTRN for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Lantern Pharma Inc (LTRN) following the 2026 Q3 hedge fund 13F filings?

As of today, LTRN has moved -34.4% since the 2026 Q3 13F filing date (November 14, 2026), compared to -6.0% for the XLV sector ETF — an outperformance of -28.4%. Since the quarter end (September 30, 2026), LTRN has gained -71.9% vs +5.4% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →